Adakveo (crizanlizumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adakveo (crizanlizumab), covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL) [Phase 2]